PHIO PHARMACEUTICALS CORP. – Trademark Portfolio
Entity Type: 03
PHIO PHARMACEUTICALS CORP. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include INTASYL. The owner is based in MARLBOROUGH, MA.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH, MA 01752
Showing of trademarks Trademarks
Trademark Classifications
PHIO PHARMACEUTICALS CORP.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PHIO PHARMACEUTICALS CORP. have?
PHIO PHARMACEUTICALS CORP. has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 6 abandoned, 8 cancelled.
What trademark classes does PHIO PHARMACEUTICALS CORP. file in?
PHIO PHARMACEUTICALS CORP. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PHIO PHARMACEUTICALS CORP.'s most well-known trademarks?
PHIO PHARMACEUTICALS CORP.'s registered trademark portfolio includes well-known marks such as INTASYL. These are among 1 currently registered trademark in the portfolio.
What is PHIO PHARMACEUTICALS CORP.'s trademark registration success rate?
PHIO PHARMACEUTICALS CORP. has a 7% trademark registration rate, with 1 out of 15 resolved applications resulting in successful registration. Currently, 1 application is pending review.